시장보고서

상품코드

1671834

과민성대장증후군 치료 시장 : 유형별, 적응증별, 약물 종류별, 투여 경로별, 유통 채널별, 지역별

Irritable Bowel Syndrome Treatment Market, By Type, By Indication, By Drug Class, By Route of Administration, By Distribution Channel, By Geography

발행일: 2025년 02월 | 리서치사:

Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 과민성대장증후군 치료 시장은 2025년 40억 4,000만 달러로 추정되며, 2025년부터 2032년까지 CAGR 9.1%로 성장하여 2032년에는 74억 3,000만 달러에 달할 것으로 예상됩니다.

보고서 범위		보고서 상세
기준 연도	2024년	2025년 시장 규모	40억 4,000만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간 : 2025-2032년 CAGR	9.10%	2032년 가치 예측	74억 3,000만 달러

그림. 과민성대장증후군 치료 시장 점유율(%), 지역별, 2025년

Irritable Bowel Syndrome Treatment Market-IMG1

과민성대장증후군(IBS)은 대장에 영향을 미치는 흔한 기능성 위장 장애로 복부 경련, 복부 팽만감, 가스, 설사, 변비 등을 유발합니다. 국립 의학 도서관의 추정에 따르면, 2024년 6월, IBS는 전 세계 인구의 약 11%에게 영향을 미칠 것으로 예상되며, IBS의 정확한 원인은 불분명하지만, 소화관이 스트레스를 처리하고 정상적인 기능과 감각을 조절하는 방식의 변화로 인한 것으로 추정됩니다. 세계 과민성대장증후군 치료 시장은 IBS의 유병률 증가와 효과적인 치료 옵션에 대한 수요 증가로 인해 지난 몇 년 동안 꾸준히 성장하고 있습니다.

시장 역학:

전 세계 과민성대장증후군 치료 시장은 노인 인구의 증가로 인해 노인들이 IBS에 걸리기 쉽기 때문에 노인 인구의 증가에 의해 주도되고 있습니다. 유엔에 따르면, 60세 이상 노인 인구는 2017년 9억 6,200만 명에서 2050년 21억 명으로 증가할 것으로 예상됩니다. 또한, IBS에 대한 인식의 증가와 진단의 개선도 이 시장의 성장을 뒷받침하고 있습니다. 그러나 IBS 치료제가 승인되지 않은 점, 신규 치료제 개발 비용이 높은 점, 기존 약물의 부작용 등이 시장 성장을 저해하는 요인으로 작용하고 있습니다. 새로운 약물 제제 및 비약물적 치료 대안의 개발은 시장에 유리한 기회를 제공할 수 있습니다.

본 조사의 주요 특징

세계의 과민성대장증후군 치료 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년)의 시장 규모와 연평균 성장률(CAGR)을 조사하여 전해드립니다.

또한, 다양한 부문에 걸친 잠재적 수익 기회를 파악하고 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.

또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.

세계 과민성대장증후군 치료 시장의 주요 기업들을 회사 개요, 제품 포트폴리오, 주요 특징, 성과, 전략 등의 매개 변수를 기반으로 프로파일링합니다.

조사 대상 주요 기업으로는 Ironwood Pharmaceuticals, Inc., AbbVie Inc., Astellas Pharma, Inc., Takeda Pharmaceutical Company Limited, AstraZeneca Plc., Sebela Pharmaceuticals, Inc., Bausch Health Companies Inc., Theriva Biologics, Inc., Ardelyx, Inc., Salix Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Abbott Laboratories, Lexicon Pharmaceuticals, Inc., GSK plc, Johnson & Johnson Services, Inc. 등이 있습니다.

이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.

세계 과민성대장증후군 치료 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.

Ironwood Pharmaceuticals, Inc.
AbbVie Inc.
Astellas Pharma, Inc.
Takeda Pharmaceutical Company Limited
AstraZeneca Plc.
Sebela Pharmaceuticals, Inc.
Bausch Health Companies Inc.
Theriva Biologics, Inc.
Ardelyx, Inc.
Salix Pharmaceuticals, Inc.
Mallinckrodt Pharmaceuticals
Abbott Laboratories
Lexicon Pharmaceuticals, Inc.
GSK plc
Johnson & Johnson Services, Inc.

제11장 애널리스트의 추천사항

Wheel of Fortune
애널리스트의 견해
Coherent Opportunity Map

제12장 참고문헌과 조사 방법

참고문헌
조사 방법
출판사 소개

ksm 25.04.10

Global Irritable Bowel Syndrome Treatment Market is estimated to be valued at US$ 4.04 Bn in 2025 and is expected to reach US$ 7.43 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	US$ 4.04 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	9.10%	2032 Value Projection:	US$ 7.43 Bn

Figure. Irritable Bowel Syndrome Treatment Market Share (%), By Region 2025

Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder that affects the large intestine. IBS causes abdominal cramping, bloating, gas, and diarrhea and/or constipation. As per National Library of Medicine estimates, in June 2024, IBS affects around 11% of people worldwide. The exact causes of IBS are unknown, but it is believed to be due to changes in the way the gastrointestinal tract handles stress and regulates normal function and sensations. The global irritable bowel syndrome treatment market has been witnessing steady growth over the past few years owing to the increasing prevalence of IBS and growing demand for effective treatment options.

Market Dynamics:

The global irritable bowel syndrome treatment market is driven by the rising geriatric population, as seniors are more prone to develop IBS. According to the United Nations, the number of people aged 60 or above will increase from 962 million globally in 2017 to 2.1 billion in 2050. Moreover, growing awareness and better diagnosis of IBS are also supporting the growth of this market. However, the lack of approved drugs for IBS, high development costs of new therapies, and side effects associated with existing drugs are some of the key factors are hampering the market growth. The development of novel drug formulations and non-drug treatment alternatives can present lucrative opportunities in the market.

Key Features of the Study:

This report provides in-depth analysis of the global irritable bowel syndrome treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global irritable bowel syndrome treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Ironwood Pharmaceuticals, Inc., AbbVie Inc., Astellas Pharma, Inc., Takeda Pharmaceutical Company Limited, AstraZeneca Plc., Sebela Pharmaceuticals, Inc., Bausch Health Companies Inc., Theriva Biologics, Inc., Ardelyx, Inc., Salix Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Abbott Laboratories, Lexicon Pharmaceuticals, Inc., GSK plc, and Johnson & Johnson Services, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global irritable bowel syndrome treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Market Segmentation

By Type Insights (Revenue, USD Bn, 2020 - 2032)
- Irritable Bowel Syndrome with Constipation (IBS-C)
- Irritable Bowel Syndrome with Diarrhea (IBS-D)
- Mixed Irritable Bowel Syndrome (IBS-M)
By Indication Insights (Revenue, USD Bn, 2020 - 2032)
- Abdominal Pain
- Bloating
- Constipation and Diarrhea
- Altered Bowel Habits
- Others
By Drug Class Insights (Revenue, USD Bn, 2020 - 2032)
- Antispasmodics
- Laxatives
- Antidiarrheal Medications
- 5-HT3 Receptor Antagonists
- Guanylate Cyclase-C Agonists
- Anticholinergic
- Probiotics
- Antidepressants
- Antibiotics
- Dietary Supplements
- Others
By Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Oral
- Rectal
- Parenteral
By Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Ironwood Pharmaceuticals, Inc.
- AbbVie Inc.
- Astellas Pharma, Inc.
- Takeda Pharmaceutical Company Limited
- AstraZeneca Plc.
- Sebela Pharmaceuticals, Inc.
- Bausch Health Companies Inc.
- Theriva Biologics, Inc.
- Ardelyx, Inc.
- Salix Pharmaceuticals, Inc.
- Mallinckrodt Pharmaceuticals
- Abbott Laboratories
- Lexicon Pharmaceuticals, Inc.
- GSK plc
- Johnson & Johnson Services, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Irritable Bowel Syndrome Treatment Market, By Type
- Global Irritable Bowel Syndrome Treatment Market, By Indication
- Global Irritable Bowel Syndrome Treatment Market, By Drug Class
- Global Irritable Bowel Syndrome Treatment Market, By Route of Administration
- Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel
- Global Irritable Bowel Syndrome Treatment Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Irritable Bowel Syndrome Treatment Market, By Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Irritable Bowel Syndrome with Constipation (IBS-C)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Irritable Bowel Syndrome with Diarrhea (IBS-D)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Mixed Irritable Bowel Syndrome (IBS-M)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Irritable Bowel Syndrome Treatment Market, By Indication, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Abdominal Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Bloating
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Constipation and Diarrhea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Altered Bowel Habits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Irritable Bowel Syndrome Treatment Market, By Drug Class, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Antispasmodics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Laxatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Antidiarrheal Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5-HT3 Receptor Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Guanylate Cyclase-C Agonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Anticholinergic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Probiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Antidepressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Dietary Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Irritable Bowel Syndrome Treatment Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Rectal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Irritable Bowel Syndrome Treatment Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Ironwood Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Astellas Pharma, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca Plc.
Sebela Pharmaceuticals, Inc.
Bausch Health Companies Inc.
Theriva Biologics, Inc.
Ardelyx, Inc.
Salix Pharmaceuticals, Inc.
Mallinckrodt Pharmaceuticals
Abbott Laboratories
Lexicon Pharmaceuticals, Inc.
GSK plc
Johnson & Johnson Services, Inc.

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us

과민성대장증후군 치료 시장 : 유형별, 적응증별, 약물 종류별, 투여 경로별, 유통 채널별, 지역별

Irritable Bowel Syndrome Treatment Market, By Type, By Indication, By Drug Class, By Route of Administration, By Distribution Channel, By Geography

시장 역학:

본 조사의 주요 특징

목차

제1장 조사 목적과 가정

제2장 시장 전망

제3장 시장 역학, 규제, 동향 분석

제4장 과민성대장증후군 치료 세계 시장, 유형별, 2020-2032년

제5장 과민성대장증후군 치료 세계 시장, 적응증별, 2020-2032년

제6장 과민성대장증후군 치료 세계 시장, 약물 종류별, 2020-2032년

제7장 과민성대장증후군 치료 세계 시장, 투여 경로별, 2020-2032년

제8장 과민성대장증후군 치료 세계 시장, 유통 채널별, 2020-2032년

제9장 과민성대장증후군 치료 세계 시장, 지역별, 2020-2032년

제10장 경쟁 구도